Trudeau Institute Inc.
Saranac Lake, New York, United States
Purpose
to evaluate in vivo efficacy of novel target regimen that include a long-acting injectable component(s) that contribute to the development of safer, simpler and shorter universal TB treatment regimen
Division
Global Health
Date
October 2025
Region Served
GLOBAL
Committed amount
$3,010,973
Grant topic
Discovery and Translational Sciences
Duration (months)
36
Grantee location
Saranac Lake, New York, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.